# MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)

> **NCT00446186** · PHASE2 · COMPLETED · sponsor: **Organon and Co** · enrollment: 945 (actual)

## Conditions studied

- Rhinitis Allergic

## Interventions

- **DRUG:** MK0476, montelukast sodium / Duration of Treatment: 2 Weeks
- **DRUG:** Comparator: placebo / Duration of Treatment: 2 Weeks

## Key facts

- **NCT ID:** NCT00446186
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2004-03
- **Final completion:** 2004-03
- **Target enrollment:** 945 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446186, "MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00446186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*